Literature DB >> 15193376

The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo.

Mark Miller1, Greg Rekas, Kelley Dayball, Yong Hong Wan, Jonathan Bramson.   

Abstract

We sought to determine whether in vivo electroporation might overcome the requirement for strong transcriptional promoters in plasmid vaccines. We tested plasmid vaccines containing viral promoters that exhibited a broad range of transcriptional activities by in vitro assay. In contrast to the in vitro observations, no difference in gene expression was measured in vivo 24h following injection when the plasmids were introduced via electroporation. Despite the similarities in gene expression in vivo, the cellular and humoral responses elicited by these plasmid vaccines were dramatically different and correlated more closely with the promoter activity measured in vitro. When antigen production in vivo was measured over a longer period following injection, significant differences in gene expression became apparent after 2-3 days and the differences in gene expression at day 7 correlated well with plasmid immunogenicity. These studies reconfirm the importance of antigen production for effective plasmid vaccination and demonstrate that the duration of gene expression should also be considered when designing plasmid vaccines.

Mesh:

Substances:

Year:  2004        PMID: 15193376     DOI: 10.1016/j.vaccine.2004.01.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer.

Authors:  C Trollet; Y Pereira; A Burgain; E Litzler; M Mezrahi; J Seguin; M Manich; M R Popoff; D Scherman; P Bigey
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

2.  Distribution and expression of recombinant plasmid encoding chicken interleukin-2.

Authors:  Z Q You; L Yu; C Z Zhang; L Li; M J Lu; Z J Mao; Y Liu; W Y Chu
Journal:  Vet Res Commun       Date:  2006-12-20       Impact factor: 2.459

Review 3.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

4.  Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity.

Authors:  Jeanette E Boudreau; Byram W Bridle; Kyle B Stephenson; Kristina M Jenkins; Jérôme Brunellière; Jonathan L Bramson; Brian D Lichty; Yonghong Wan
Journal:  Mol Ther       Date:  2009-04-28       Impact factor: 11.454

5.  Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging.

Authors:  Stefan P Petkov; Frank Heuts; Olga A Krotova; Athina Kilpelainen; Gunnel Engström; Elizaveta S Starodubova; Maria G Isaguliants
Journal:  Hum Vaccin Immunother       Date:  2013-07-03       Impact factor: 3.452

6.  Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee.

Authors:  C Bloquel; C Trollet; E Pradines; J Seguin; D Scherman; M F Bureau
Journal:  BMC Biotechnol       Date:  2006-03-08       Impact factor: 2.563

7.  DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.

Authors:  Stefan Petkov; Elizaveta Starodubova; Anastasia Latanova; Athina Kilpeläinen; Oleg Latyshev; Simons Svirskis; Britta Wahren; Francesca Chiodi; Ilya Gordeychuk; Maria Isaguliants
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.